Rats and mice exposed to repeated stress or a single severe stress exhibit a sustained increase in energetic, endocrine, and behavioral response to subsequent novel mild stress. This study tested whether the hyper-responsiveness was due to a lowered threshold of response to corticotropin releasing factor (CRF) or an exaggerated response to a standard dose of CRF. Male Sprague-Dawley rats were subjected to 3 h of restraint on each of 3 consecutive days (RRS) or were non-restrained controls. RRS caused a temporary hypophagia but a sustained reduction in body weight. Eight days after the end of restraint, rats received increasing third ventricle doses of CRF (0-3.0 μg). The lowest dose of CRF (0.25 μg) increased corticosterone release in RRS, but not control rats. Higher doses caused the same stimulation of corticosterone in the two groups of rats. Fifteen days after the end of restraint, rats were food deprived during the light period and received increasing third ventricle doses of CRF at the start of the dark period. The lowest dose of CRF inhibited food intake during the first hour following infusion in RRS, but not control rats. All other doses of CRF inhibited food intake to the same degree in both RRS and control rats. The lowered threshold of response to central CRF is consistent with the chronic hyper-responsiveness to CRF and mild stress in RRS rats during the post-restraint period.
Introduction
Rats subjected to 3 h of restraint stress experience a sustained reduction in body weight (Rybkin et al., 1997) . Repetition of restraint on three consecutive days (RRS) maximizes the weight loss (Harris et al., 2002) , which is maintained for at least 3 months (Harris et al., 2006) . Downregulation of body weight has also been reported for rats exposed to other stressors including social defeat (Meerlo et al., 1996) and immobilization (Valles et al., 2000) . RRS also causes sustained changes in the endocrine response to stress represented by an exaggerated corticosterone release in response to mild stress, but the same response as controls to more severe stress (Harris et al., 2004) . Similar observations have been made in rats exposed to 2 h of immobilization (Belda et al., 2008) or scrambled footshock every 90 s for 30 min (Belda et al., 2004) . In addition, it is well established that acute or chronic stress modifies behavior in the post-stress period. For example, social defeat causes a long-term inhibition of social interaction (Watt et al., 2009) and impairment of working memory (Novick et al., 2013) . These data suggest that exposure to stress causes a sustained change in the sensitivity or responsiveness of central mechanisms that control behavioral and physiological responses to subsequent stressors.
Hyperreactivity could be achieved either by lowering the threshold for response or by amplifying the response to a standard concentration of receptor agonist. We measured the effect of corticotropin releasing factor (CRF) injected into the third ventricle on corticosterone release and on food intake of rats that had previously been subjected to RRS. We previously reported that third ventricle injection of the CRFR1 antagonist antalarmin prevents the sustained reduction in body weight of RRS of rats (Chotiwat and Harris, 2008) , which implies that the long-term effects of RRS are initiated in an area adjacent to the ventricle.
Methods
All procedures were approved by the Institutional Animal Care and Use Committee of Augusta University and followed National Institute of Health guidelines for care and use of laboratory animals. Eighty male Sprague-Dawley rats (Envigo RMS, IN) entered the study in three cohorts in which all treatment groups were equally represented. They were housed individually in hanging wire mesh cages at 21°C with lights on for 12 h a day from 6.00 a.m. with free access to food (Harlan Teklad Rodent Diet 8604) and water except where specified. After 1 week of adaptation, they were fitted with third ventricle guide cannula as described previously (Chotiwat and Harris, 2008) . Cannula placement was verified 7 days later by infusion of 20 ng angiotensin II in 2 μl of sterile saline. Rats that drank water within 2 min of infusion were included in the experiment. All infusions were delivered from Hamilton syringes controlled by an infusion pump (PHD 2000 Infusion pump, Harvard Apparatus, MA). Four rats failed to drink following the angiotensin II injection and 3 additional rats were removed later in the study when their cannulas became loose. Rats were given 2 days to recover from the angiotensin II infusion before the experiment started.
Daily body weights and food intake corrected for spillage were recorded for 6 days and then the rats were divided into two weightmatched groups. One group was subjected to RRS. At 8.00 a.m., they were placed in Perspex restraining tubes (21.6 × 6.4 cm, Plas Labs, MI) in an experimental room. Controls were housed in shoe box cages without food or water in the same room. After 3 h, all rats were returned to their home cage. Restraint was repeated on three consecutive days. The first day of RRS was day 0 of the experiment, food intake was measured until 5 days after the end of restraint, and body weights were recorded throughout the experiment. On day 8, food was removed from the cages at 7.00 a.m. Control and RRS groups were each subdivided into five weight-matched groups. Starting at 9.00 a.m., a small blood sample was collected from the tail of each rat immediately before they received a 2 μl 3rd ventricle infusion of saline or 0.25, 0.5, 1.0, or 3.0 μg CRF. This was considered time 0. Additional blood samples were collected exactly 30, 60, 90, and 120 min after infusion. Food was returned to the cages at the end of blood sampling. Samples were centrifuged and serum corticosterone concentration measured ( Corticosterone (ng/ml) Fig. 1 . Food intake, body weight, and HPA activation in RRS and control rats. Daily food intake (A) and weight change (B) in control and RRS rats. RRS rats were subjected to 3 h of restraint on days 0, 1, and 2 of the experiment and control and RRS rats were injected with different doses of CRF on days 8 and 15. Data are means ± SEM for 36 or 37 rats. Serum corticosterone measured 8 days after the end of RRS during the 2 h following a third ventricle infusion of different doses of CRF is shown in panels C-G and panel H shows area under the curve for serum corticosterone. Data are means ± SEM for groups of 5 or 6 rats. Asterisks indicate significant differences between control and RRS rats. Values for area under the curve that do not share a common superscript are significantly different.
0.25, 0.5, 1.0, or 3.0 μg CRF. Food was returned to the cages at 6.00 p.m., and intake was recorded 1, 2, 4, and 6 h after infusion. Body weight was monitored for an additional 3 days. Significant differences in weight gain, food intake, and corticosterone were determined by repeated-measures analysis of variance using Statistica version 9.0 (StatSoft, OK) and post hoc Duncan's multiple range test. P b 0.05 was considered significant. Effect size comparisons were performed for ANOVA (Eta-squared = effect sum of squares/total sum of squares). Single measure comparisons were made by unpaired t test assuming equal variance and effect size calculated as Cohen's d.
Results
Food intake of RRS rats was inhibited on the days of restraint, but then returned to control levels (Fig. 1A) . Because these rats did not compensate for the hypophagia, total intake during days 0-8 was significantly lower in RRS than control rats (188 ± 2 vs 203 ± 3, df = 73, Cohen's d = 0.68). Control and RRS rats weighed the same on day 0 (control: 324 ± 3 g, RRS: 318 ± 3 g), but RRS rats lost 16.4 ± 1.4 g during RRS whereas controls gained 5.4 ± 1.9 g (RRS: P b 0.001 df = 1, F = 134, Eta-squared = 0.91; Day: P b 0.4, df = 2, F = 1, Eta-squared = 0.001; RRS × Day: P b 0.001, df = 2, F = 72, Eta-squared = 0.08). The difference in weight was maintained to the end of the experiment because the two groups gained weight at the same rate following RRS (Fig. 1B) . All control and RRS rats lost weight during the 24 h following CRF infusion, but there was no significant effect of CRF dose in either group. They gained weight again within 48 h, but there was no effort to compensate for the weight loss.
H: 6 Hours
Third ventricle infusions of CRF caused a dose-dependent increase in serum corticosterone. There was no difference in corticosterone release in control and RRS rats receiving 0, 0.5, 1.0, or 3.0 μg CRF (Fig. 1C, E-G) , but corticosterone was significantly higher in RRS than control rats infused with 0.25 μg CRF (Fig. 1D : RRS: P b 0.008, df = 1, F = 11, Etasquared = 0.43; Time: P b 0.001, df = 4, F = 12, Eta-squared = 0.54; Interaction: P b 0.7, df = 4, F = 0.5, Eta-squared = 0.02). Calculation of area under the curve indicated that 0.25 μg CRF had no effect on corticosterone in control rats compared with those receiving 0 μg CRF, whereas it stimulated corticosterone release in RRS rats to the same levels as that achieved by 0.5 μg CRF (Fig. 1H) . Because peak corticosterone concentration continued to increase with CRF dose, it was not possible to determine whether we had reached maximal response in rats injected with 3.0 μg CRF. Area under the curve was not different for rats receiving 1.0 or 3.0 μg CRF, but because corticosterone remained elevated at 120 min, this plateau was likely an artifact of the sampling protocol.
Third ventricle infusion of CRF on day 15 of the experiment caused a dose-dependent inhibition of food intake in rats that had been food deprived during the day (Fig. 2) . During the first hour after the infusion, both control and RRS rats infused with 0.5, 1, or 3 μg CRF ate significantly less than rats infused with saline. A dose of 0.25 μg CRF significantly inhibited food intake in RRS, but not control rats ( Fig. 2A) . This initial inhibition was compensated for between 2 and 4 h after infusion (Fig. 2C ) and cumulative intake was the same for all of the rats at 4 and 6 h postinfusion ( Fig. 2G and H) .
Discussion
Sustained changes in behavior and HPA activity following acute stress are well documented for rodent models and it has been reported that exposure to a single severe stress desensitizes the HPA axis to that stress, but increases reactivity to novel stressors (Belda et al., 2008) . The neural basis of the chronic effects of acute stress has not been fully elucidated, but the impact on neurogenesis and methylation of DNA are being investigated and involvement of noradrenergic (Curtis et al., 1995) and serotonergic systems (Berton et al., 1999 ) is well established. Noradrenergic neurons in the locus coeruleus have been implicated in the emotional and cognitive responses to stress (Sullivan et al., 1999) , and recently, the sustained increase in anxiety following repeated social stress has been associated with adrenergic-dependent inflammation in this area (Wohleb et al., 2011) .
We have reported that RRS rats maintain a reduced body weight compared with their controls and have an exaggerated sensitivity to mild stress in the post-stress period. Hyperreactivity of the HPA axis has also been reported for animals subjected to more natural stressors such as overcrowding (Ortiz et al., 1985) . This study suggests that exposure to RRS lowers the threshold of response to CRF because the lowest dose tested here (0.25 μg) increased corticosterone and inhibited food intake of RRS, but not control rats, whereas there was no difference between the two groups in their response to higher doses of CRF. These results are consistent with our previous observation that RRS rats show an exaggerated corticosterone release and reduce food intake in response to the mild stress of an intraperitoneal injection of saline, whereas the response to the more extreme physiologic stress of 2-deoxyglucose-induced hypoglycemia is the same for control and RRS rats (Harris et al., 2004) .
We did not test the molecular basis for the lowered threshold of response. Inhibition of CRF binding protein expression would result in an apparent lowering of the response threshold because a greater amount of free CRF would be available to bind to receptors (Behan et al., 1995) ; however, it has been reported that restraint stress stimulates expression of the binding protein, which would attenuate CRF response (Herringa et al., 2004) . We have reported that activation of CRFR1 during RRS initiates at least some of the long-term effects of stress (Chotiwat and Harris, 2008) , and we (Harris et al., 2006) and others (Imaki et al., 1996) have shown that restraint stress causes an acute increase in expression of CRFR1 in the paraventricular nucleus of the hypothalamus of rats. This could enhance the effect of CRF on HPA activity and food intake, but the increase in receptor expression is not maintained in the post-RRS period (Harris et al., 2006) . Additionally, it has recently been reported that HPA reactivity is independent of CRFR1 activation (Belda et al., 2012) . Recovery of homeostasis following acute stress is achieved by glucocorticoid negative feedback on the hypothalamus and pituitary, but Belda (Belda et al., 2012) also demonstrated that HPA reactivity is not due to a failure of negative feedback. Therefore, the increased sensitivity to low doses of CRF may be due to a post-receptor event, rather than the dynamics of CRF receptor binding which would be consistent with conclusions made from an earlier study measuring CRF-evoked discharge of locus coeruleus neurons in rats subjected to repeated sessions of footshock (Curtis et al., 1995) .
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